Genetic deletion of detoxific enzyme gstm1 and GSTT1 as a host susceptible factor for nasopharyngeal carcinoma

  • Deng Zhuo-lin 
  • Wei Yi-ping 
  • Ma Yun 


Objective: To study the gene polymorphisms of GSTT1 and GSTM1 in nasopharyngeal carcinoma (NPC) patients and controls in an incidental area to evaluate the relationship between specific genotype and genotype combinations of these polymorphisms with the risk of NPC. Methods: Cases and controls all came from the Southwestern Guangxi. DNAs were extracted from their WBC. PCR technique was used to calculate the deletion rate of the two detoxific enzyme genes. Results: In this high risk area of NPC, the residents had high level deletion rates of 47.4% (64/135) Ml and T1 40.7% (55/135). The deletion rates were even higher in NPC patients, 61.5% (56/91) for Ml and 59.3% (54/91) for T1 respectively. There were statistical significances compared with control,P<0.05 andP<0.01 for Ml and T1 respectively. The difference was more significant in terms of combined Ml and T1 deletion between patients and controlsx 2=12.533,P=0.002. Conclusion: The combined deletion of detoxific enzyme genes GSTM1 and GSTT1 may be an important genetic susceptible factor for NPC in Guangxi.

Key words

Nasopharyngeal carcinoma Genetic susceptibility Glutathione S-transferase polymorphism 

CLC number



  1. [1]
    Chen H, Lee JM, Zong YS. Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors [J]. J Virol 2001; 75:2929–37.PubMedCrossRefGoogle Scholar
  2. [2]
    Niedobitek G, Meru N, Delecluse HJ. Epstein-Barr virus infection and human malignancies [J]. Int J Exp Pathol 2001; 82:149–70.PubMedCrossRefGoogle Scholar
  3. [3]
    Brockmoller J, Kerb R, Drakoulis N, et al. Glutathione S-transferase Ml and its variants A and B as host factors of bladder cancer susceptibility: a case-control study [J]. Cancer Res 1994; 54:4103–11.PubMedGoogle Scholar
  4. [4]
    Pemble S, Schroeder KR, Spencer SR. Human glutathione-S-transferase theta GSTT1: cDNA cloning and the characterization of a genetic polymorphism [J]. Biochem J 1994; 300:271–6.PubMedGoogle Scholar
  5. [5]
    Kim JW, Lee CG, Park YG, et al. Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1 and CYP2E1, relation to the incidence rate of cervical carcinoma [J]. Cancer 2000; 88:2082–91.PubMedCrossRefGoogle Scholar
  6. [6]
    Bell DA, Taylor JA, Paulson DF, et al. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen metabolism gene glutathione S-transferase Ml (GSTM1) that increases susceptibility to bladder cancer [J]. J Natl Cancer Inst 1993; 85:1159–64.PubMedCrossRefGoogle Scholar
  7. [7]
    Cheng L, Sturgis EM, Eicher SA, et al. Glutathione S-transferase polymorphisms and risk of squamous-cell carcinoma of the head and neck [J]. Int J Cancer 1999; 84:220–4.PubMedCrossRefGoogle Scholar
  8. [8]
    Tiemersma EW, Omer RE, Bunschoten A. Role of genetic polymorphism of glutathione-S-transferase T1 and microsomal epoxide hydrolase in aflatoxin-associated hepatocellular carcinoma [J]. Cancer Epidemiol Biomarkers Prev 2001; 10:785–91.PubMedGoogle Scholar
  9. [9]
    Gersler SA, Olshan AF. GSTM1, GSTT1 and the risk of squamous cell carcinoma of the head and neck [J]. Am J Epidemiol 2001; 154:95–105.CrossRefGoogle Scholar
  10. [10]
    Whalen R, Boyer TD. Human glutathione S-transferases [J]. Semin Liver Dis 1998; 18:345–58.PubMedCrossRefGoogle Scholar
  11. [11]
    Norppa H. Genetic susceptibility, biomarker respones, and cancer [J]. Mutat Res 2003; 554:339–48.Google Scholar

Copyright information

© Chinese Journal of Cancer Research 2004

Authors and Affiliations

  • Deng Zhuo-lin 
    • 1
  • Wei Yi-ping 
    • 1
  • Ma Yun 
    • 1
  1. 1.Department of PathologyGuangxi Medical UniversityNanning

Personalised recommendations